The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.


U.S. Appeals Court Strikes Down FTC Order Against TurboTax "Free" Advertising
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
O'Hare Flight Cuts: Chicago Pushes Back as FAA Weighs Summer Limits
FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
U.S. Deploys Elite 82nd Airborne Troops to Middle East Amid Iran Tensions
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
U.S. Pulls Back Proposed AI Chip Export Rule Amid Policy Uncertainty
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
FCC Chairman Threatens Broadcasters Over "Fake News" Amid Iran War Coverage Debate 



